Cited by 328Gut microbiota and healthNutritional Studies and DietPolyamine Metabolism and Applications

l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans

Open access
Koeth, Robert A., Lam-Galvez, Betzabe Rachel, Kirsop, Jennifer, Wang, Zeneng, Levison, Bruce S., Gu, Xiaodong, Copeland, Matthew F., Bartlett, David +11 more·2018·Journal of Clinical Investigation

Abstract

BACKGROUND: l-Carnitine, an abundant nutrient in red meat, accelerates atherosclerosis in mice via gut microbiota-dependent formation of trimethylamine (TMA) and trimethylamine N-oxide (TMAO) via a multistep pathway involving an atherogenic intermediate, γ-butyrobetaine (γBB). The contribution of γBB in gut microbiota-dependent l-carnitine metabolism in humans is unknown. METHODS: Omnivores and vegans/vegetarians ingested deuterium-labeled l-carnitine (d3-l-carnitine) or γBB (d9-γBB), and both plasma metabolites and fecal polymicrobial transformations were examined at baseline, following oral antibiotics, or following chronic (≥2 months) l-carnitine supplementation. Human fecal commensals capable of performing each step of the l-carnitine→γBB→TMA transformation were identified. RESULTS: Studies with oral d3-l-carnitine or d9-γBB before versus after antibiotic exposure revealed gut microbiota contribution to the initial 2 steps in a metaorganismal l-carnitine→γBB→TMA→TMAO pathway in subjects. Moreover, a striking increase in d3-TMAO generation was observed in omnivores over vegans/vegetarians (>20-fold; P = 0.001) following oral d3-l-carnitine ingestion, whereas fasting endogenous plasma l-carnitine and γBB levels were similar in vegans/vegetarians (n = 32) versus omnivores (n = 40). Fecal metabolic transformation studies, and oral isotope tracer studies before versus after chronic l-carnitine supplementation, revealed that omnivores and vegans/vegetarians alike rapidly converted carnitine to γBB, whereas the second gut microbial transformation, γBB→TMA, was diet inducible (l-carnitine, omnivorous). Extensive anaerobic subculturing of human feces identified no single commensal capable of l-carnitine→TMA transformation, multiple community members that converted l-carnitine to γBB, and only 1 Clostridiales bacterium, Emergencia timonensis, that converted γBB to TMA. In coculture, E. timonensis promoted the complete l-carnitine→TMA transformation. CONCLUSION: In humans, dietary l-carnitine is converted into the atherosclerosis- and thrombosis-promoting metabolite TMAO via 2 sequential gut microbiota-dependent transformations: (a) initial rapid generation of the atherogenic intermediate γBB, followed by (b) transformation into TMA via low-abundance microbiota in omnivores, and to a markedly lower extent, in vegans/vegetarians. Gut microbiota γBB→TMA/TMAO transformation is induced by omnivorous dietary patterns and chronic l-carnitine exposure. TRIAL REGISTRATION: ClinicalTrials.gov NCT01731236. FUNDING: NIH and Office of Dietary Supplements grants HL103866, HL126827, and DK106000, and the Leducq Foundation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci94601

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. l-carnitine). Cultures were grown under anaerobic conditions at 37°C for 12 days, diluting 1:100 in enrichment media every 2 days. After 12 days in culture, enriched communities were spread and plated in BHI plates supplemented with 500 μM l-carnitine. To reduce the complexity of the microbial community, single colonies, groups of 2-3 colonies, and groups of 4+ colonies totaling 768 cultures were then picked and inoculated into 1 ml of BHI containing 50 μM d 9 -l-carni- tine. After 24 hours at 37°C under anaerobic conditions, a sample of culture supernatant was collected and quenched by addition of formic acid to a final concentration of 0.1%. The amount of d 9 -TMA produced was determined by LC-MS/MS. The top d 9 -TMA-producing well was selected and replated, repeating the community simplification steps as described above. Once the top d 9 -TMA-producing community was identified, the cells were spread and plated. Single colonies were iso- lated and identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) using a Biotyp- er System (Bruker Daltonics Inc.) (64). Isolates with similar high- confidence identification were pooled into 4 separate species pools, SP1 through SP4. All isolates with no reliable identification by MS were pooled into a fifth pool, SP5, and subsequently identified by 16S-rRNA sequence analysis (AccuGENX-ID, Accugenix). Single microbial isolates or pools of isolates were evaluated alone or in combination for their ability to catabolize compounds of the l-carnitine pathway. Starter cultures were grown in BHI for 24 hours at 37°C under anaerobic conditions. Cells were harvested by centrifu- gation and washed in M9 minimal medium. After washing, cells were resuspended in M9 supplemented with 50 μM d 9 -l-carnitine or 50 μM d 9 -γBB as indicated. For kinetic experiments with fecal communities, fecal slurries prepared as described above were used instead of starter cultures. Reactions were allowed to proceed for up to 32 hours at 37°C under anaerobic conditions, as indicated. Samples of culture super- natant quenched by addition of formic acid to a final concentration of 0.1% were analyzed by LC-MS/MS to quantify concentrations of d 9 -TMA, d 9 -l-carnitine, and/or d 9 -γBB. Human fecal polymicrobial incubation with deuterium-labeled l-car- nitine and γBB. Human fecal samples were collected, snap-frozen in glycerol stock using liquid nitrogen, and maintained at -80°C until use. Feces (50 mg) was incubated with 1 ml reaction solution contain- ing 150 mM d 3 -l-carnitine, d 9 -l-carnitine, or d 9 -γBB as indicated with- in 10 mM HEPES, pH 7.4, in a gas-tight reaction vial under anaerobic (Argon) conditions at 37°C. Reactions were stopped 16 hours later by addition of formic acid to a final concentration of 0.1%. The products were determined by LC-MS/MS with d 4 -choline and 13 C 3 , 15 N-TMA added as internal standards and normalized to mass of fecal content. General statistics. A Mann-Whitney (Wilcoxon rank sum test) 2-tailed nonparametric test or a Pearson χ 2 test was used to compare group means and AUCs. A Wilcoxon matched-pairs test or a zero- inflated linear mixed-effects model was used to assess linked human and baseline treatment effects as deemed appropriate. A repeated- measures 1-way ANOVA test was used to assess differences of base- line plasma concentrations of γBB and TMAO between multiple visits. For all analyses a P value less than 0.05 was considered significant. All

Cited by

Sorted by citations

Authors
Koeth, R. A., Lam-Galvez, B. R., Kirsop, J., Wang, Z., Levison, B. S., Gu, X., Copeland, M. F., Bartlett, D., Cody, D. B., Dai, H. J., Culley, M. K., Li, X. S., Fu, X., Wu, Y., Li, L., DiDonato, J. A., Tang, W. H. W., Garcia-Garcia, J. C., & Hazen, S. L.
Affiliations
  • Cleveland Clinic (US)
  • Cleveland Clinic Lerner College of Medicine (US)
  • Procter & Gamble (United States) (US)
  • Cleveland State University (US)
Venue
Journal of Clinical Investigation
Published
2018-12-10
Volume
129
Issue
1
Pages
373-387
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2903641122
Cited by
327
References
65
Citations by year
2026: 25 · 2025: 44 · 2024: 37 · 2023: 48 · 2022: 47 · 2021: 51 · 2020: 51 · 2019: 23 · 2018: 1
FWCI
11.21
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
NIH and Office of Dietary Supplements (HL103866, HL126827, DK106000)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Polyamine Metabolism and Applications
Keywords
L-carnitine, trimethylamine N-oxide, trimethylamine, gamma-butyrobetaine, gut microbiota, atherosclerosis, omnivorous diet, vegan diet, Clostridiales, antibiotic exposure, plasma carnitine
MeSH terms
Vegans, Eubacteriales, Clostridiales, Gastrointestinal Microbiome, Animals, Betaine, Carnitine, Female, Humans, Male, Methylamines, Pilot Projects, Atherosclerosis, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review